Suspended

CAPNOTOXContinuous EtCO2 Monitoring in Acute Self Poisoned Patients Admitted in an Emergency Department

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being collected

Data Collection

Collected from today forward - Prospective
Who is being recruted

Drug Misuse+4

+ Mental Disorders

+ Substance-Related Disorders

Over 18 Years
+6 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Cohort

Tracking disease incidence in order to identify risk factors and understand disease progression over time.
Observational
Study Start: March 2012
See protocol details

Summary

Principal SponsorUniversity Hospital, Grenoble
Study ContactMaxime Maignan, MDMore contacts
Last updated: February 27, 2013
Sourced from a government-validated database.Claim as a partner

Study start date: March 1, 2012

Actual date on which the first participant was enrolled.

There is no consensus on monitoring criteria in acute self poisoning. Clinical scores, vital signs or lactatemia have failed to prove good predictive value. The main acute self poisoning complication is decreased consciousness level with consequent increased risk of hypoxemia and aspiration pneumonitis. Several clinical studies have recently shown that EtCO2 monitoring can be valuable in procedural sedation in the emergency department. It is able to predict hypoxemia before any SaO2 decrease and any complications related to these procedures. We therefore hypothesized that EtCO2 could help in acute self poisoning patients' monitoring in the ED.

NCT01800123
Principal SponsorUniversity Hospital, Grenoble
Study ContactMaxime Maignan, MDMore contacts
Last updated: February 27, 2013
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

200 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Cohort

These studies follow a group of individuals with common characteristics (such as a condition or birth year) over a specific period to study health outcomes or exposures.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Over 18 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Drug MisuseMental DisordersSubstance-Related DisordersPrescription Drug MisuseChemically-Induced DisordersPoisoningDrug Overdose

Criteria

4 inclusion criteria required to participate
18y/o
acute self poisoning patients
patients not requiring invasive ventilation at ED admission
patients requiring monitoring according to physician's opinion
2 exclusion criteria prevent from participating
Pregnant woman
patients deprived of liberty

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

One single intervention group is designated in this study

This study does not include a placebo group 

Treatment Groups

Study Objectives

Primary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Recruiting

Genoble university hospital

Grenoble, FranceOpen Genoble university hospital in Google Maps
SuspendedOne Study Center